These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 8216456

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Nonlinear pharmacokinetic modeling of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging.
    Schuhmann-Giampieri G.
    Arzneimittelforschung; 1993 Sep; 43(9):1020-4. PubMed ID: 8240452
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Biliary excretion and pharmacokinetics of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging in the rat.
    Schuhmann-Giampieri G, Schmitt-Willich H, Frenzel T, Schitt-Willich H [corrected to Schmitt-Willich H].
    J Pharm Sci; 1993 Aug; 82(8):799-803. PubMed ID: 8377117
    [Abstract] [Full Text] [Related]

  • 5. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system.
    Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, Negishi C, Weinmann HJ, Speck U.
    Radiology; 1992 Apr; 183(1):59-64. PubMed ID: 1549695
    [Abstract] [Full Text] [Related]

  • 6. Hepatic kinetics and magnetic resonance imaging of gadolinium-EOB-DTPA in dogs.
    Benness G, Khangure M, Morris I, Warwick A, Burrows P, Vogler H, Weinmann HJ.
    Invest Radiol; 1996 Apr; 31(4):211-7. PubMed ID: 8721960
    [Abstract] [Full Text] [Related]

  • 7. [A comparative study between Gd-BOPTA, a biliary excretion contrast medium, and Gd-DTPA in the magnetic resonance imaging of the rat liver].
    Patrizio G, Pavone P, Cardone G, Pietroletti R, Passariello R, Tettamanti E, Musu C, Felder E.
    Radiol Med; 1990 May; 79(5):458-62. PubMed ID: 2359853
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of gadoxetate disodium as a contrast agent for mouse liver imaging: comparison with gadobenate dimeglumine.
    Kiryu S, Inoue Y, Watanabe M, Izawa K, Shimada M, Tojo A, Yoshikawa K, Ohtomo K.
    Magn Reson Imaging; 2009 Jan; 27(1):101-7. PubMed ID: 18599243
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of the liver-specific contrast agent Gd-EOB-DTPA in relation to contrast-enhanced liver imaging in humans.
    Schuhmann-Giampieri G, Mahler M, Röll G, Maibauer R, Schmitz S.
    J Clin Pharmacol; 1997 Jul; 37(7):587-96. PubMed ID: 9243351
    [Abstract] [Full Text] [Related]

  • 10. Characterization of the intestinal and hepatic uptake/efflux transport of the magnetic resonance imaging contrast agent gadolinium-ethoxylbenzyl-diethylenetriamine-pentaacetic acid.
    Jia J, Puls D, Oswald S, Jedlitschky G, Kühn JP, Weitschies W, Hosten N, Siegmund W, Keiser M.
    Invest Radiol; 2014 Feb; 49(2):78-86. PubMed ID: 24056116
    [Abstract] [Full Text] [Related]

  • 11. Quantification of dechelation of gadopentetate dimeglumine in rats.
    Kasokat T, Urich K.
    Arzneimittelforschung; 1992 Jun; 42(6):869-76. PubMed ID: 1418049
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics and stability of caldiamide sodium in rats.
    Okazaki O, Kurata T, Yoshioka N, Hakusui H.
    Arzneimittelforschung; 1996 Jan; 46(1):79-83. PubMed ID: 8821523
    [Abstract] [Full Text] [Related]

  • 13. Hepatobiliary enhancement with Gd-EOB-DTPA: comparison of spin-echo and STIR imaging for detection of experimental liver metastases.
    Mühler A, Clément O, Vexler V, Berthezène Y, Rosenau W, Brasch RC.
    Radiology; 1992 Jul; 184(1):207-13. PubMed ID: 1609081
    [Abstract] [Full Text] [Related]

  • 14. Hepatic kinetics and magnetic resonance imaging of gadolinium ethoxybenzyl diethylenetriaminepentacetic acid (Gd-EOB-DTPA) in dogs.
    Benness G, Khangure M, Morris I, Warwick A, Burrows P.
    Australas Radiol; 1993 Aug; 37(3):252-5. PubMed ID: 8373327
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A macromolecular contrast agent for magnetic resonance imaging. Effect of molecular weight on blood pharmacokinetics and enhancement patterns for polylysine-gadopentetate dimeglumine.
    Vexler VS, Clément O, Brasch RC.
    Invest Radiol; 1994 Jun; 29 Suppl 2():S62-4. PubMed ID: 7928273
    [No Abstract] [Full Text] [Related]

  • 17. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
    Dahlström N, Persson A, Albiin N, Smedby O, Brismar TB.
    Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
    [Abstract] [Full Text] [Related]

  • 18. Phantom and animal studies of a new hepatobiliary agent for MR imaging: comparison of Gd-DTPA-DeA with Gd-EOB-DTPA.
    Yoshikawa K, Inoue Y, Akahane M, Shimada M, Itoh S, Seno A, Hayashi S.
    J Magn Reson Imaging; 2003 Aug; 18(2):204-9. PubMed ID: 12884333
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Gadocoletic acid trisodium salt (b22956/1): a new blood pool magnetic resonance contrast agent with application in coronary angiography.
    de Haën C, Anelli PL, Lorusso V, Morisetti A, Maggioni F, Zheng J, Uggeri F, Cavagna FM.
    Invest Radiol; 2006 Mar; 41(3):279-91. PubMed ID: 16481911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.